Heidelberg Pharma AG
DUS:HPHA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
H
|
Heidelberg Pharma AG
DUS:HPHA
|
DE |
|
B
|
Beigene Ltd
XMUN:49B
|
KY |
|
B
|
Banc of California Inc
F:FPB
|
US |
Intrinsic Value
The intrinsic value for
Heidelberg Pharma AG (HPHA) under the Base Case is 2.27 EUR.
Compared with the current market price of 2.45 EUR, the stock appears
Overvalued by 7% .
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Heidelberg Pharma AG.
The intrinsic value for
Heidelberg Pharma AG (HPHA) under the Base Case is 2.27 EUR.
Compared with the current market price of 2.45 EUR, the stock appears Overvalued by 7% .